Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving viable micro-organism
Patent
1991-04-26
1993-12-14
Robinson, Douglas W.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving viable micro-organism
435 2, 435 32, 4352402, 436501, C12Q 102, C12Q 118, A01N 102, C12N 500
Patent
active
052701727
ABSTRACT:
A method is disclosed for predicting response of a tumor patient to therapy, and selecting appropriate therapy for malignant neoplasms such as breast, ovarian and gastrointestinal cancer. A sample of tumor cells is cultured in the presence of 10 .mu.g/ml estradiol, and inhibition of cell growth in the culture paradoxically indicates an estrogen dependent tumor that will respond to antiestrogenic therapy. Another sample of tumor cells is cultured in the presence of a chemotherapeutic agent which predicts response of the tumor to in vivo administration of a cytotoxic agent. The chemotherapeutic agent is preferably a cytotoxic drug, or a drug having both cytotoxic and antiestrogenic mechanisms of action. A particularly suitable substance having both mechanisms of action is: ##STR1## wherein R.sup.1 H, OH, OOC(CH.sub.2).sub.2 CO.sub.2 H or CH.sub.3 COO; R.sup.2 is C.sub.6 H.sub.4 OH, C.sub.6 H.sub.4 OCOCH.sub.3, C.sub.6 H.sub.4 OOC(CH.sub.2)CO.sub.2 H, or C.sub.6 H.sub.5 ; and X is C.sub.6 H.sub.3 -2,4(NO.sub.2).sub.2, C.sub.6 H.sub.5, C.sub.6 H.sub.4 -4(NO.sub.2), C.sub.6 H.sub.4 -3(NO.sub.2), or C.sub.6 H.sub.3 -2,4(NO.sub.2).sub.2 ;
Predictive power of the assay is increased by combining information from the estradiol and chemotherapeutic assays. These assays are preferably performed in culture flasks having removable bases that function as conventional microscope slides.
REFERENCES:
patent: 3726764 (1971-08-01), White
patent: 4465676 (1984-08-01), Hochberg
patent: 4732904 (1988-03-01), Morgan
Vescio et al., "In vivo-like Drug Responses of Human Tumors Growing in Three-Dimensional Gel-Supported Primary Culture", Proc. Natl. Acad. Sci. U.S.A., 84:5029-5033, (Jul. 1987).
Fan et al., "Comparison of Antitumor Activity of Standard and Investigational Drugs at Equivalent Granulocyte-Macrophage Colony-forming Cell Inhibitory Concentrations in the Adhesive Tumor Cell Culture System: An in vitro Method of Screening New Drugs", Eur. J. Cancer Clin. Oncol., 23:1469-1476 (1987).
Tueni et al., "In Vitro Activity of Bleomycin, Tallysomycin S10b, and Liblomycin Against Fresh Human Tumor Cells", Cancer Research, 49:1099-1102 (Mar. 1989).
Watanabe et al., "In Vitro Sensitivitiy Test of Breast Cancer Cells to Hormonal Agents in a Radionucleotide-Incorporation Assay", Japanese Journal of Cancer Research, 81:536-543 (May 1990).
Coezy et al., Cancer Research, 42, pp. 317-323.
Dekk-Tek, Inc.
Robinson Douglas W.
Williams Jane A.
LandOfFree
Method to predict tumor response to therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method to predict tumor response to therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method to predict tumor response to therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1704399